Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label study of oxycodone/naloxone for patient preference after prior WHO step I or II analgesics in non-malignant pain
2008-001026-14Phase 3Completed
- Sponsor
- Mundipharma
- Start
- Dec 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of oxycodone and naloxone in pain, sponsored by Mundipharma. Primary endpoint: Patient preference with respect to quality of life. Started Dec 2008; status: completed.
02
Drugs
oxycodonenaloxone
03
Conditions
pain
Beyond the preview
Go deeper on 2008-001026-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001026-14.